Insulin Copay Bill Advances In What Could Be US Senate Democrats Last Gasp For Price Reform

Though popular, the proposal to cap insulin copays is a relatively minor part of the drug pricing reform package included in the stalled Build Back Better Act. But it may represent Democrats’ best chance of passing any drug pricing-related legislation while they still hold majorities in Congress.